-
Adult Primary MN at Risk of Progression?
-
MAJESTY: Give 1,000 mg IV Weeks 0, 2, 24, 26
-
Do Not Initiate Obinutuzumab; Treat Barrier or Redirect
-
Adult Active LN Receiving Standard Therapy?
-
REGENCY: Give 1,000 mg IV Weeks 0, 2, 24, 26, Then Every 6 Months
-
Do Not Initiate Obinutuzumab; Treat Barrier or Redirect
-
Refractory, Relapsing, or Rituximab-Intolerant AAV?
-
Off-Label AAV: 1,000 mg IV Once or Weeks 0 and 2
-
Do Not Initiate Obinutuzumab; Treat Barrier or Redirect
-
Age ≥2 With Childhood-Onset FRNS or SDNS in Complete Remission?
-
INSHORE: ≥45 kg 1,000 mg; <45 kg 20 mg/kg at Weeks 0, 2, 24, 26
-
Do Not Initiate Obinutuzumab; Treat Barrier or Redirect
-
MCD, Cryoglobulinemic GN, or Other Emerging Disease?